Idylla ctKRAS Mutation Assay (RUO)
A0081/6
The fully automated IdyllaTM ctKRAS Mutation Assay is minimally invasive, fast and easy to perform and can be used as complement to tissue testing to determine the RAS mutation status at diagnosis. IdyllaTM ctKRAS covers 21 KRAS mutations in exons 2,3 and 4 and showed an high concordance to NGS of 96% using plasma samples from 198 mCRC patients enrolled in the prospective multicenter RASANC study.1
- 1Jacobs et al. Journal of Clinical Oncology 2017; 35,15_suppl e15127
Specimen requirements
One of the biggest challenges in oncology biomarker testing is the ability to obtain samples of sufficient size and quality. With the IdyllaTM System only a minimal amount of sample is needed
- 1 ml plasma collected in Streck tubes (process within 3 days)
